Twitter Beğeni Hilesi

Precision prediction of HF events in patients with #DCMmrEF using multi-parametric #WhyCMR: Prospective observational cohort study 📌Among 355 patients (median LVEF 49%, median f/up 7.8 years), LV GLS was linked to HF events (HR 2.70 for LV GLS > -15.4%). 📌#LGE presence was

🔥 Implementation of #GDMT for #HeartFailure : Progress achieved, work ahead ! 🏋️‍♀️ Still a lot of job to do to implement #GDMT #HF ☠️ still not significantly changed due to poor use of new therapies! #HFUA EJHF Editor-in-Chief Amr Abdin Henry Han European Society of Cardiology Journals Gregg Fonarow MD Michele Emdin

Intravenous ferric carboxymaltose and reduced risk of hospital admissions for Heart Failure and cardiovascular causes! Read the results from meta-analysis on #EHJ! #cardiotwitter #ehj #heart #failure #iron #deficiency @ESC_journals European Society of Cardiology academic.oup.com/eurheartj/arti…

Decongestion in #AHF : Is it time to change #diuretic-centred paradigm? This fantastic review discusses the latest in decongestive therapies for #HeartFailure Jan Biegus Marco Metra European Society of Cardiology Journals onlinelibrary.wiley.com/doi/full/10.10… Henry Han Amr Abdin Giuseppe Galati

#Congestion is a common cause of clinical deterioration and the most common clinical presentation at admission in 📌#AHF This review presents a new perspective on decongestive therapy for #HeartFailure , moving beyond #diuretic-centered treatments. onlinelibrary.wiley.com/doi/full/10.10…

👉 Biomarkers of lung congestion and injury in acute heart failure. Read all about it in #ESCHeartFailure bit.ly/3ySBifw EJHF Editor-in-Chief Jan Biegus #HFA_ESC Harriette Van Spall, MD MPH Shelley Zieroth Marat Fudim, MD MHS Gregg Fonarow MD Jozine ter Maaten Amr Abdin Giuseppe Galati Henry Han Wilfried Mullens

Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the #DECISION trial The DECISION trial will provide important evidence regarding the effect of (low-dose) #digoxin on CV mortality and total HF 🏥 and urgent hospital visits when

🔥 #RESHAPE_HF2 NEJM confirmed an important role of #MitraClip in #FMR & #HFrEF : 👉 ⬇️ CV-☠️ + #HHF 🏥 ❗️Major driver is ⬇️ #HHF ✅ Similar effects of #ARNI & #SGLT2i 👉 Intermediate characteristics among #COAPT & #MITRA_FR #HFUA EJHF Editor-in-Chief Gregg Fonarow MD bit.ly/3MpXO2z

#RESHAPE_HF unveiled the grey part of the 🌖 The major benefit of #MITRA_Clip in ⬇️ #HHF Intermediate characteristics between #MITRA_FR & #COAPT & intermediate results between the 2 trials 🔥 🤝 Drug & devices similar effects in #HFrEF Michele Emdin bit.ly/4f5DkJD

Implementing Medical Therapy During Worsening Heart Failure Ankeet S. Bhatt, MD, MBA Muthu Vaduganathan academic.oup.com/eurheartj/adva… #WHF #HeartFailure #ESCCongress European Society of Cardiology Journals European Society of Cardiology EJHF Editor-in-Chief

Beta-blocker use and outcomes in patients with #HeartFailure and mildly reduced and preserved ejection fraction released at #ESCCongress and just published in #EJHF👉 bit.ly/3Tbt2hr EJHF Editor-in-Chief Faiez ZANNAD

🔥❤️‍🔥 #FINEARTS_HF. #FineHearts_HF #Finerenone confirmed a 16% RRR of #CV ☠️ & Total #HHF 🏥 A 2nd pillar for #HFmrEF & #HFpEF has just been built 🏛️ #HFUA EJHF Editor-in-Chief NEJM Gregg Fonarow MD James Januzzi Jr MD Andrew J Sauer MD BiykemBozkurt Michele Emdin Ritu Thamman MD Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦 bit.ly/3TdO13r

🗞️ #EXPAND : Impact of #HeartFailure Hospitalizations ( #HHF ) on clinical outcomes after #mitral TEER #EJHF 🔝 European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han HFAPresident bit.ly/3Z843j6

🔥 #EXPAND : A real life study that confirms that the major driver of benefits of #MitraClip in #FMR & #HFrEF 👉⬇️ #HHF 🏥 & ⬆️ of #QoL See Tweet2👇 #HFUA European Society of Cardiology Journals EJHF Editor-in-Chief Amr Abdin Henry Han Gregg Fonarow MD Michele Emdin James Januzzi Jr MD Ritu Thamman MD bit.ly/3Z843j6

#Sacubitril/valsartan reduces incident #anaemia and iron therapy utilization in heart failure: The #PARAGON-HF trial European Society of Cardiology Journals Muthu Vaduganathan Carolyn Lam Pardeep S Jhund scottdavidsolomon Full 📝 👇🏻 onlinelibrary.wiley.com/doi/full/10.10… Henry Han Amr Abdin Giuseppe Galati Marco Metra

🗞️ #DECISION A new #RCT on low dose of #digoxin in #HeartFailure with #LVEF < 50% both sinus rhythm & #AF #EJHF 🔝 European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han HFAPresident bit.ly/3MAEtMb

🔥#DECISION A new #RCT on #digoxin in #HF with #LVEF < 50% both sinus rhythm & #AF Will be the last trial on the topic? Maybe with a final answer 🍀 #HFUA European Society of Cardiology Journals EJHF Editor-in-Chief Amr Abdin Henry Han Michele Emdin Gregg Fonarow MD James Januzzi Jr MD Shelley Zieroth Kamala Tamirisa MD

Impact of age on clinical outcomes and response to # in patients with acute heart failure: An analysis from the #RELAX-AHF-2 trial onlinelibrary.wiley.com/doi/full/10.10… European Society of Cardiology Journals Marco Metra #EJHF #AHF #HeartFailure Henry Han Amr Abdin Giuseppe Galati

Among 16951 pts, BBs do not worsen outcomes (CV🪦+HF🏥) in HFmrEF/HFpEF. 👉However, large #RCT required to confirm causal relationships bit.ly/3Tbt2hr Amr Abdin EJHF Editor-in-Chief Giuseppe Galati Henry Han Pardeep S Jhund Muthu Vaduganathan #EJHF

🔥Back in the #HFACommittees It’s always a pleasure🤝 #HypertrophicCardiomyopathy 🫀#HCM Chairperson iacopo olivotto 🍀 HFAPresident EJHF Editor-in-Chief #HFUA Roberto Franco Enrico Pedretti Dr.Rajiv Sankaranarayanan Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Anna Kate Barton Kamala Tamirisa MD Ritu Thamman MD Erik Rafflenbeul Michele Emdin Giuseppe Limongelli